INTERVIEW: Dr. Reddy’s CEO On Move From Curing Diseases To Managing Health (Part 2 of 2)
This article was originally published in PharmAsia News
Executive Summary
G.V. Prasad, the CEO of Dr. Reddy’s Laboratories Ltd. is known for his big picture views. In this second part of a freewheeling interview, Prasad shared his thoughts on diverse subjects, most striking of all was the vision to shift gears from curing diseases to managing health.
You may also be interested in...
Set On Competing With Merck And Roche, Dr Reddy's Labs Pins Hopes On CETP Drug
MUMBAI - Despite the odds against developing a robust pipeline of innovative drugs, Kallam Anji Reddy, founder and chairman of the $1.36 billion Dr. Reddy's Labs, refuses to give up the chase to discover new drugs
India IPR Realities: Pharma, Legal Heads Discuss Winds Of Change, ‘Damocles Sword’
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving intellectual property rights landscape, including pre-grant oppositions, enforcement action and other realities. Concerns around evergreening, restrictions on patent-eligible subject matter and compulsory licensing were also key talking points at a recent conference in Hyderabad.
India IPR Wheels Are Turning: Novartis, Bayer, Sun, Legal Heads Discuss Realities
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving intellectual property rights landscape, including pre-grant oppositions, enforcement action and other realities. Concerns around evergreening, restrictions on patent-eligible subject matter and compulsory licensing were also key talking points at a recent conference in Hyderabad.